These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7401312)

  • 41. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs".
    Nguyen HM; Graber CJ
    Int J Antimicrob Agents; 2020 Oct; 56(4):106085. PubMed ID: 32659466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
    Ginsburg CM; McCracken GH
    J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical evaluation on S-6436 (author's transl)].
    Suzuki H; Iwasaki H; Ra S; Matsumoto K
    Kansenshogaku Zasshi; 1977 Jun; 51(6):317-20. PubMed ID: 411844
    [No Abstract]   [Full Text] [Related]  

  • 44. [Relationship between urinary antimicrobial concentration and MIC--in clinical studies on S-6436 (author's transl)].
    Doi T; Kawada Y; Nishiura T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):327-34. PubMed ID: 411846
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical results of cefadroxil in children and pharmacokinetics of the drug (author's transl)].
    Takimoto M; Cho K; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1981 Feb; 34(2):140-2. PubMed ID: 7253191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Peroral cephalosporin. (Our initial results of treatment with cephalexin-Keflex)].
    Tajfl D; Krstić S; Gajić S
    Vojnosanit Pregl; 1973; 30(4):264-8. PubMed ID: 4768021
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefadroxil in the treatment of soft tissue infections.
    Ballantyne F
    J Int Med Res; 1980; 8(Suppl 1):64-9. PubMed ID: 7439508
    [No Abstract]   [Full Text] [Related]  

  • 50. Oral cefadroxil in the treatment of bone and joint infections in children and adults.
    Jimenez-Shehab M; Barragan A
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():149-52. PubMed ID: 6821596
    [No Abstract]   [Full Text] [Related]  

  • 51. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Miyazu M; Osuga T
    Jpn J Antibiot; 1981 Jan; 34(1):77-94. PubMed ID: 7241809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 53. [The comparison of blood levels between peripheral vein and tooth extraction wound after the oral administration of antibiotics (author's transl)].
    Hashimoto T; Ookawa H; Morishita M; Takeyasu K; Shiiki K; Imoto T
    Jpn J Antibiot; 1981 Jun; 34(6):942-5. PubMed ID: 7289043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacokinetics of cefadroxil, a new oral cephalosporin (author's transl)].
    Simon C
    Arzneimittelforschung; 1980; 30(3):502-4. PubMed ID: 7387764
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the toxicity of cefadroxil (S-578). V. Fertility study in rats (author's transl)].
    Tauchi K; Kawanishi H; Igarashi N; Maeda Y; Maeyama Y; Ebino K; Suzuki K; Imamichi T
    Jpn J Antibiot; 1980 Apr; 33(4):478-86. PubMed ID: 7411852
    [No Abstract]   [Full Text] [Related]  

  • 56. Cephalexin nephrotoxicity. Reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy.
    Fung-Herrera CG; Mulvaney WP
    JAMA; 1974 Jul; 229(3):318-9. PubMed ID: 4406795
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical test of cefalexin in chronic urinary infections].
    Scheidt J; Schach H; Neussel H
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1860-4. PubMed ID: 4564651
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical studies on S-6436 in the urological and gynecological infections (author's transl)].
    Takase Z
    Kansenshogaku Zasshi; 1977 Jun; 51(6):353-5. PubMed ID: 411849
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)].
    Takamoto H; Kamata H; Hirano M; Niijima T; Onoda T
    Kansenshogaku Zasshi; 1977 Jun; 51(6):343-52. PubMed ID: 411848
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experience with S-6436 in urinary tract infections (author's transl)].
    Yamamoto H; Oida S; Ohtsuki A; Hosomi T; Kubo Y
    Jpn J Antibiot; 1977 Oct; 30(10):825-8. PubMed ID: 592485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.